Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Inari Medical, Inc. regarding a class action lawsuit due to alleged misleading statements and omissions that inflated the company's stock price during the specified class period [1][5]. Group 1: Class Action Details - The class period for the lawsuit is from February 23, 2022, to February 28, 2024, with a deadline for registration set for July 12, 2024 [3][6]. - Shareholders who purchased shares of Inari Medical during this period are encouraged to register for the class action and may be eligible for recovery [4][6]. Group 2: Allegations Against Inari Medical - The complaint alleges that the defendants made materially false and/or misleading statements and failed to disclose critical information, leading to an artificial inflation of Inari's stock price [5]. - It is claimed that these actions caused shareholders to purchase Inari common stock at prices that did not reflect its true value [5]. Group 3: Next Steps for Shareholders - Registered shareholders will be enrolled in a portfolio monitoring system to receive updates on the case's progress [6]. - There is no cost or obligation for shareholders to participate in the class action [6].

Class Period: Feb. 24, 2022 – Feb. 28, 2024 Lead Plaintiff Deadline: July 12, 2024 Visit: www.hbsslaw.com/investor-fraud/nari Contact the Firm Now: NARI@hbsslaw.com 844-916-0895 Inari Medical Class Action: The investigation came to light in late February, triggering a sharp decline in Inari's stock price and prompting a class-action lawsuit from concerned investors. On February 29, 2024, Inari disclosed that it had received a Civil Investigative Demand (CID) from the DOJ's Civil Division in December 2023. T ...

NEW YORK, June 17, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Inari Medical, Inc. (NASDAQ: NARI). CONTACT US HERE: CLASS PERIOD: February 23, 2022 to February 28, 2024 NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of NARI during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff ...

https://zlk.com/pslra-1/inari-medical-inc-lawsuit-submission-form?prid=84960&wire=4 NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate. NARI investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500. WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieve ...

Core Viewpoint - A class action lawsuit has been filed against Inari Medical, Inc. for alleged violations of securities laws, specifically related to misleading statements about the company's financial performance and improper compensation practices [1][5]. Group 1: Lawsuit Details - The lawsuit pertains to investors who purchased Inari's securities between February 24, 2022, and February 28, 2024, during which the company allegedly made false claims about its revenue [2][5]. - The Schall Law Firm is representing the investors and encourages those who suffered losses to contact them before July 12, 2024 [2][3]. Group 2: Allegations Against Inari - The complaint alleges that Inari falsely claimed "record revenues" due to the strength of its core VTE business while actually engaging in improper compensation of medical professionals, violating federal laws [5]. - The misleading public statements made by Inari resulted in significant damages to investors once the truth was revealed [5].

NEW YORK, June 10, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Inari Medical, Inc. (NASDAQ: NARI) between February 24, 2022 and February 28, 2024, both dates inclusive (the "Class Period"), of the important July 12, 2024 lead plaintiff deadline. SO WHAT: If you purchased Inari Medical common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee a ...

Shareholders who purchased shares of NARI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. https://securitiesclasslaw.com/securities/inari-medical-inc-loss-submission-form/?id=83233&from=4 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) the Company deceived ...

NEW YORK, June 07, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Inari Medical, Inc. ("Inari Medical" or the "Company") (NASDAQ: NARI) of a class action securities lawsuit. https://zlk.com/pslra-1/inari-medical-inc-lawsuit-submission-form?prid=83070&wire=3 CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (i) the Company deceived the investing public, including plaintiff; (ii) cause the market price of Inari common stock to trade ab ...

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its ...

SAN FRANCISCO, June 06, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Inari Medical, Inc. (NASDAQ: NARI) investors who suffered substantial losses to submit your losses now. Class Period: Feb. 24, 2022 – Feb. 28, 2024 Lead Plaintiff Deadline: July 12, 2024 Visit: www.hbsslaw.com/investor-fraud/nari Contact the Firm Now: NARI@hbsslaw.com 844-916-0895 Inari Medical, Inc. (NARI) Class Action: Inari Medical, a medical device manufacturer, is bracing for a protracted investigation by the Department of Justice (DO ...